Entheon Biomedical continues into British Columbia from federal jurisdiction

PUBT · 1d ago
Entheon Biomedical continues into British Columbia from federal jurisdiction
  • Entheon Biomedical Corp. completed a corporate continuance from the Canada Business Corporations Act into British Columbia under the BCBCA.
  • Shareholders authorized the move at the annual general and special meeting held on Sept. 29, 2026.
  • Corporate governance documents were replaced with new notice of articles and articles under British Columbia law.
  • CUSIP, ISIN, and the common-share stock symbol remained unchanged.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entheon Biomedical Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610081849NEWSFILECNPR____20261008_318177_1) on October 08, 2026, and is solely responsible for the information contained therein.